Delic Holdings Corp.’s DELCF subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.
Starting on May 9, the clinics in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson will introduce the new therapy to their offerings.
NAD+ is a fundamental coenzyme found in every cell of the body thought to have multiple beneficial effects, especially in maintaining cell health. The problem is that with age NAD+ levels naturally decrease.
Currently, there are numerous brands that sell the molecule as a supplement, such as Tru Niagen, Bulletproof, Theagehack and UltraNMN, but the offering for intravenous or intramuscular administration is much lower.
"The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being,” commented Kevin Nicholson, CEO of Delic and KWC.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!